Gilead Sciences, Inc.
GILD
•Stock Analysis$110.67
+0.00 (+0.00%)• Live
Gilead Sciences, Inc. Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Gilead Sciences, Inc.
Key Financial Metrics
for Gilead Sciences, Inc.
P/E Ratio
22.83
Revenue Growth
+6.04%
EPS Growth
-91.63%
Market Cap
$135.96B
Dividend Yield
+2.84%
Debt/Equity
1.30
ROIC
+15.32%
FCF Yield
+7.24%
View additional metrics
Valuation
P/B Ratio7.11
EV/Sales5.32
Financial Health
Current Ratio1.37
Return on Assets+20.74%
Analyst Recommendations
for Gilead Sciences, Inc.
57 analysts
Consensus: Buy
About
for Gilead Sciences, Inc.
Company Details
for Gilead Sciences, Inc.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Daniel P. O'Day
Employees
17,600
Market Cap
137.67B
Exchange
NASDAQ Global Select
IPO Date
January 22, 1992
Website
www.gilead.comCIK
0000882095
ISIN
US3755581036
CUSIP
375558103
Country
US
Balance Sheet
for Gilead Sciences, Inc.
Cash Flow Statement
for Gilead Sciences, Inc.
Income Statement
for Gilead Sciences, Inc.
News
No news available at the moment.